Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (331-340 of 451) with videos related to

Pageof 46
Sort By:
The American Journal of Cardiology|July 16, 2019
Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study)Atul Verma, Rolf Wachter, Peter R Kowey, et al.
Chest|February 16, 2013
Cardiovascular safety in patients receiving roflumilast for the treatment of COPDWilliam B White, Glen E Cooke, Peter R Kowey, et al.
Circulation. Arrhythmia and Electrophysiology|July 24, 2023
Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial FibrillationKrishna Pundi, Jun Fan, Shaum Kabadi, et al.
The American Journal of Cardiology|April 2, 2017
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])Benjamin A Steinberg, DaJuanicia N Simon, Laine Thomas, et al.
Circulation|October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE InvestigatorsJ D Rutherford, M A Pfeffer, L A Moyé, et al.
American Heart Journal|March 7, 2021
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trialMintu Turakhia, Vandana Sundaram, Shea N Smith, et al.
Clinical Cardiology|March 18, 2010
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective surveyPeter R Kowey, Günter Breithardt, John Camm, et al.
Journal of the American Heart Association|May 23, 2015
Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, DaJuanicia Simon, Benjamin A Steinberg, et al.
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Clinical Cardiology|November 24, 2004
Characteristics of contemporary patients with hypertension and coronary artery diseaseRhonda M Cooper-DeHoff, Eileen M Handberg, Jerome Cohen, et al.
Pageof 46

Showing results (331-340 of 451) with videos related to

Sort By:
Pageof 46
The American Journal of Cardiology|July 16, 2019
Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study)Atul Verma, Rolf Wachter, Peter R Kowey, et al.
Chest|February 16, 2013
Cardiovascular safety in patients receiving roflumilast for the treatment of COPDWilliam B White, Glen E Cooke, Peter R Kowey, et al.
Circulation. Arrhythmia and Electrophysiology|July 24, 2023
Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial FibrillationKrishna Pundi, Jun Fan, Shaum Kabadi, et al.
The American Journal of Cardiology|April 2, 2017
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])Benjamin A Steinberg, DaJuanicia N Simon, Laine Thomas, et al.
Circulation|October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE InvestigatorsJ D Rutherford, M A Pfeffer, L A Moyé, et al.
American Heart Journal|March 7, 2021
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trialMintu Turakhia, Vandana Sundaram, Shea N Smith, et al.
Clinical Cardiology|March 18, 2010
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective surveyPeter R Kowey, Günter Breithardt, John Camm, et al.
Journal of the American Heart Association|May 23, 2015
Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Fredrik Holmqvist, DaJuanicia Simon, Benjamin A Steinberg, et al.
American Heart Journal|May 16, 2016
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAnna Gundlund, Emil Loldrup Fosbøl, Sunghee Kim, et al.
Clinical Cardiology|November 24, 2004
Characteristics of contemporary patients with hypertension and coronary artery diseaseRhonda M Cooper-DeHoff, Eileen M Handberg, Jerome Cohen, et al.
Pageof 46